About Nines
Nines is a Healthcare company based in San Francisco (United States) founded in 2017 by Alexander C Kagen. AI-based radiology operating system is developed for clinicians. Nines has raised $16.5 million across 2 funding rounds from investors including Accel and 8VC. Nines offers products and services including RadOS, Diagnostic Viewer, and Reporter. Its focus areas include HealthTech, Clinical Labs IT, Radiology and Image Analysis. Its legal entity is Sirona Medical, Inc. Its competitors include Subtle Medical, Invicro and Arterys; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2017 and headquartered in San Francisco, United States, Nines operates in the AI medical imaging sector. An AI-based device known as NinesAI is utilized to support teleradiology practices for radiologists. Patient care is facilitated through enhanced imaging analysis and workflow tools. The platform is designed to integrate with clinical operations, enabling remote diagnostics and collaboration across healthcare settings. Co-founder Alexander C. Kagen contributes to its development.
- Total Equity Funding$16.5M (USD)
in 2 rounds
- Latest Funding Round$16.5M (USD), Series A
Nov 2019
- InvestorsAccel
& 1 more
Products & Services of Nines
Nines offers a comprehensive portfolio of products and services, including RadOS, Diagnostic Viewer, and Reporter.
Cloud-native software for efficient radiology workflows and data management
Tool for viewing and analyzing medical images quickly
Software for generating radiology reports accurately
Apps and channels of Nines
its YouTube channel Sirona Medical has 72 subscribers and 30 videos.
Videos from Nines
The most watched videos on Nines's YouTube channel, Sirona Medical (72 subscribers). Click a video to play it here.
More on Sirona Medical.
Funding Insights of Nines
Nines has successfully raised a total of $16.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $16.5 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.5M
- Total Rounds 2
- Last Round Series A — $16.5M
- Investors Count 2
All 2 funding rounds of Nines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Nines
Nines has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Accel and 8VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Accel is recognized as a leading venture capital firm. | 1983 | accel.com | Palo Alto, United States | |
Venture capital firm investing in technology, life sciences, and related sectors. | 8vc.com |
Investor details for Nines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nines
38 people are tracked at Nines (13 in leadership, 6 in board & advisors, 19 in team).
| Name | Role | Group |
|---|---|---|
Alexander C Kagen | Co-Founder | Leadership |
Aidan Andrews | Chief of Staff | Leadership |
Mark Longo | CTO | Leadership |
Cameron Andrews | CEO | Leadership |
Fred Ong | CFO | Leadership |
Alan Kaye | CMO | Leadership |
Greg Stock | Vice President, People | Leadership |
Mark D. Longo, Ph.D. | Chief Technology Innovation Officer (ctio) | Leadership |
Patrice JC Nedelec 🇺🇦 🇺🇸🇫🇷 | Vice-President, Quality Management and Regulatory Affairs | Leadership |
Paul Gardner | Vice President Of Engineering | Leadership |
Brett Stolberg | Director Of Sales Development And Enablement | Leadership |
Ryan Dougherty | Enterprise Sales Director | Leadership |
Todd Murdoch | Enterprise Sales Director - West | Leadership |
Robert Baumgartner | Advisor | Board & advisors |
Jeff Queisser | Advisor | Board & advisors |
Chris Wood | Advisor | Board & advisors |
John Pavlidis | Advisor | Board & advisors |
Curt Langlotz | Advisor | Board & advisors |
Ronald Paulus | Advisor | Board & advisors |
Jun (Ryan) Zhang | Senior Software Engineer | Team |
18 more people are available in the full profile.
Complete people profiles for Nines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nines
3 dated milestones of Nines across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Nines is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $16.5M.
Competitors of Nines
Nines has 3 listed competitors in our database, 3 of them funded. They include Subtle Medical, Invicro and Arterys.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| subtlemedical.com | 2017 | Palo Alto, United States | $18.3M | 23 | AI-driven solutions for medical diagnostic imaging are developed. | |
| invicro.com | 2008 | Boston, United States | $45.84M | 308 | Provide contract research imaging services and software | |
| arterys.com | 2012 | San Francisco, United States | $70.2M | 20 | SaaS analytics platform for Medical Image Analysis |
Detailed competitors of Nines
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Nines (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nines
Complete news archive for Nines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nines
Nines was founded in 2017.
Nines is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nines is a funded company, having raised a total of $16.5M across 2 funding rounds to date.
Founded in 2017 and headquartered in San Francisco, United States, Nines operates in the AI medical imaging sector. An AI-based device known as NinesAI is utilized to support teleradiology practices for radiologists. Patient care is facilitated through enhanced imaging analysis and workflow tools. The platform is designed to integrate with clinical operations, enabling remote diagnostics and collaboration across healthcare settings. Co-founder Alexander C. Kagen contributes to its development.
Nines's top competitors include Subtle Medical, Invicro and Arterys.
Nines offers RadOS, Diagnostic Viewer, and Reporter.
Nines operates through Sirona Medical, Inc..